5 cancer organizations join Harvard Business School's Kraft Precision Medicine Accelerator

Boston-based Harvard Business School's Kraft Precision Medicine Accelerator added five cancer organizations that are collaborating to advance precision medicine opportunities across the cancer care arena.

The organizations include:

• LUNGevity Foundation
• Metastatic Breast Cancer Alliance
• Multiple Myeloma Research Foundation
• Pancreatic Cancer Action Network
• Prostate Cancer Foundation

The accelerator is focused on developing a business framework to share solutions that help advance precision medicine. It will work to enhance four elements of precision medicine: direct to patient; data and analytics; clinical trials; and venture and investment.

It is currently testing the "Right Track," a framework that connects cancer patients with patient-focused organizations to enable them to optimize their treatment journey. The framework was developed using market research that pinpointed gaps in knowledge and actions among patients with five types of cancer.

More articles on precision medicine:
Study predicts patients' disease risks using emergency contacts
Intermountain expands precision genomics DNA test to all providers
UCSF Health, UChicago Medicine partner with Color to offer patients genetic tests

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months